{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:40:42Z","timestamp":1792568442177,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["PIBPG2022-132145\/2023-5"],"award-info":[{"award-number":["PIBPG2022-132145\/2023-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Estado de Santa Catarina","doi-asserted-by":"publisher","award":["FAPESC - 2021TR001543"],"award-info":[{"award-number":["FAPESC - 2021TR001543"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11302-026-10193-z","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:53:50Z","timestamp":1792508030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological melatonin induces mitochondrial dysfunction and alters extracellular nucleotide metabolism and CD39\/CD73 expression in human melanoma cells"],"prefix":"10.1007","volume":"22","author":[{"given":"Bruna Cristina","family":"Ozelame","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiane","family":"M\u00e2nica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilnei Bruno","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia Machado","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete Dulce","family":"Bagatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8518-7959","authenticated-orcid":false,"given":"Aline","family":"M\u00e2nica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"10193_CR1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4287","author":"G Leonardi","year":"2018","unstructured":"Leonardi G, Falzone L, Salemi R et al (2018) Cutaneous melanoma: from pathogenesis to therapy (review). Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2018.4287","journal-title":"Int J Oncol"},{"key":"10193_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, Van Akkooi ACJ, Berking C et al (2018) Melanoma. Lancet 392:971\u2013984. https:\/\/doi.org\/10.1016\/S0140-6736(18)31559-9","journal-title":"Lancet"},{"key":"10193_CR3","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.3390\/ijms22073485","volume":"22","author":"M Osrodek","year":"2021","unstructured":"Osrodek M, Wozniak M (2021) Targeting genome stability in melanoma\u2014a new approach to an old field. Int J Mol Sci 22:3485. https:\/\/doi.org\/10.3390\/ijms22073485","journal-title":"Int J Mol Sci"},{"key":"10193_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126388","volume":"23","author":"A Villani","year":"2022","unstructured":"Villani A, Potestio L, Fabbrocini G et al (2022) The treatment of advanced melanoma: therapeutic update. Int J Mol Sci 23:6388. https:\/\/doi.org\/10.3390\/ijms23126388","journal-title":"Int J Mol Sci"},{"key":"10193_CR5","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1002\/jcb.26551","volume":"119","author":"A Manica","year":"2018","unstructured":"Manica A, Da Silva AM, Cardoso AM et al (2018) High levels of extracellular ATP lead to chronic inflammatory response in melanoma patients. J Cell Biochem 119:3980\u20133988. https:\/\/doi.org\/10.1002\/jcb.26551","journal-title":"J Cell Biochem"},{"key":"10193_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cellsig.2019.03.021","volume":"59","author":"A M\u00e2nica","year":"2019","unstructured":"M\u00e2nica A, Da Silva Rosa Bonadiman B, Cardoso AM et al (2019) The signaling effects of ATP on melanoma-like skin cancer. Cell Signal 59:122\u2013130. https:\/\/doi.org\/10.1016\/j.cellsig.2019.03.021","journal-title":"Cell Signal"},{"key":"10193_CR7","doi-asserted-by":"publisher","first-page":"472","DOI":"10.20945\/2359-3997000000066","volume":"62","author":"FGD Amaral","year":"2018","unstructured":"Amaral FGD, Cipolla-Neto J (2018) A brief review about melatonin, a pineal hormone. Arch Endocrinol Metab 62:472\u2013479. https:\/\/doi.org\/10.20945\/2359-3997000000066","journal-title":"Arch Endocrinol Metab"},{"key":"10193_CR8","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1007\/s00018-014-1579-2","volume":"71","author":"D Acu\u00f1a-Castroviejo","year":"2014","unstructured":"Acu\u00f1a-Castroviejo D, Escames G, Venegas C et al (2014) Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci 71:2997\u20133025. https:\/\/doi.org\/10.1007\/s00018-014-1579-2","journal-title":"Cell Mol Life Sci"},{"key":"10193_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jid.2017.10.025","volume":"138","author":"AT Slominski","year":"2018","unstructured":"Slominski AT, Hardeland R, Zmijewski MA et al (2018) Melatonin: a cutaneous perspective on its production, metabolism, and functions. J Invest Dermatol 138:490\u2013499. https:\/\/doi.org\/10.1016\/j.jid.2017.10.025","journal-title":"J Invest Dermatol"},{"key":"10193_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18040843","volume":"18","author":"R Reiter","year":"2017","unstructured":"Reiter R, Rosales-Corral S, Tan D-X et al (2017) Melatonin, a full service anti-cancer agent: inhibition of initiation, progression and metastasis. Int J Mol Sci 18:843. https:\/\/doi.org\/10.3390\/ijms18040843","journal-title":"Int J Mol Sci"},{"key":"10193_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1036-z","volume":"38","author":"J Hao","year":"2019","unstructured":"Hao J, Fan W, Li Y et al (2019) Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS\/hTERT signaling and cancer-stem cell traits. J Exp Clin Cancer Res 38:48. https:\/\/doi.org\/10.1186\/s13046-019-1036-z","journal-title":"J Exp Clin Cancer Res"},{"key":"10193_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/molecules23030518","volume":"23","author":"WH Talib","year":"2018","unstructured":"Talib WH (2018) Melatonin and cancer hallmarks. Molecules 23:518. https:\/\/doi.org\/10.3390\/molecules23030518","journal-title":"Molecules"},{"key":"10193_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116960","volume":"238","author":"K Mortezaee","year":"2019","unstructured":"Mortezaee K, Potes Y, Mirtavoos-Mahyari H et al (2019) Boosting immune system against cancer by melatonin: a mechanistic viewpoint. Life Sci 238:116960. https:\/\/doi.org\/10.1016\/j.lfs.2019.116960","journal-title":"Life Sci"},{"key":"10193_CR14","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.3390\/ijms14023901","volume":"14","author":"M Bonmati-Carrion","year":"2013","unstructured":"Bonmati-Carrion M, \u00c1lvarez-S\u00e1nchez N, Hardeland R et al (2013) A comparison of B16 melanoma cells and 3T3 fibroblasts concerning cell viability and ROS production in the presence of melatonin, tested over a wide range of concentrations. Int J Mol Sci 14:3901\u20133920. https:\/\/doi.org\/10.3390\/ijms14023901","journal-title":"Int J Mol Sci"},{"key":"10193_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-cellbio-120420-015303","volume":"38","author":"K Shen","year":"2022","unstructured":"Shen K, Pender CL, Bar-Ziv R et al (2022) Mitochondria as cellular and organismal signaling hubs. Annu Rev Cell Dev Biol 38:179\u2013218. https:\/\/doi.org\/10.1146\/annurev-cellbio-120420-015303","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10193_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cells8030275","volume":"8","author":"D Yang","year":"2019","unstructured":"Yang D, Kim J (2019) Mitochondrial retrograde signalling and metabolic alterations in the tumour microenvironment. Cells 8:275. https:\/\/doi.org\/10.3390\/cells8030275","journal-title":"Cells"},{"key":"10193_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/onc.2016.206","volume":"36","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Adinolfi E (2017) Extracellular purines, purinergic receptors and tumor growth. Oncogene 36:293\u2013303. https:\/\/doi.org\/10.1038\/onc.2016.206","journal-title":"Oncogene"},{"key":"10193_CR18","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1158\/0008-5472.CAN-12-1600","volume":"72","author":"F Di Virgilio","year":"2012","unstructured":"Di Virgilio F (2012) Purines, purinergic receptors, and cancer. Cancer Res 72:5441\u20135447. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1600","journal-title":"Cancer Res"},{"key":"10193_CR19","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/cells9071612","volume":"9","author":"ADR Campos-Contreras","year":"2020","unstructured":"Campos-Contreras ADR, D\u00edaz-Mu\u00f1oz M, V\u00e1zquez-Cuevas FG (2020) Purinergic signaling in the hallmarks of cancer. Cells 9:1612. https:\/\/doi.org\/10.3390\/cells9071612","journal-title":"Cells"},{"key":"10193_CR20","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454:436\u2013444. https:\/\/doi.org\/10.1038\/nature07205","journal-title":"Nature"},{"key":"10193_CR21","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/cancers11050656","volume":"11","author":"J Eberle","year":"2019","unstructured":"Eberle J (2019) Countering TRAIL resistance in melanoma. Cancers (Basel) 11:656. https:\/\/doi.org\/10.3390\/cancers11050656","journal-title":"Cancers (Basel)"},{"key":"10193_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01818","volume":"10","author":"A Montfort","year":"2019","unstructured":"Montfort A, Colacios C, Levade T et al (2019) The TNF paradox in cancer progression and immunotherapy. Front Immunol 10:1818. https:\/\/doi.org\/10.3389\/fimmu.2019.01818","journal-title":"Front Immunol"},{"key":"10193_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1055\/a-0656-6643","volume":"69","author":"D Mahmood","year":"2019","unstructured":"Mahmood D (2019) Pleiotropic effects of melatonin. Drug Res (Stuttg) 69:65\u201374. https:\/\/doi.org\/10.1055\/a-0656-6643","journal-title":"Drug Res (Stuttg)"},{"key":"10193_CR24","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1159\/000438587","volume":"37","author":"W Li","year":"2015","unstructured":"Li W, Fan M, Chen Y et al (2015) Melatonin induces cell apoptosis in AGS cells through the activation of JNK and P38 MAPK and the suppression of nuclear factor-kappa B: a novel therapeutic implication for gastric cancer. Cell Physiol Biochem 37:2323\u20132338. https:\/\/doi.org\/10.1159\/000438587","journal-title":"Cell Physiol Biochem"},{"key":"10193_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","volume":"19","author":"L Antonioli","year":"2013","unstructured":"Antonioli L, Pacher P, Vizi ES et al (2013) CD39 and CD73 in immunity and inflammation. Trends Mol Med 19:355\u2013367. https:\/\/doi.org\/10.1016\/j.molmed.2013.03.005","journal-title":"Trends Mol Med"},{"key":"10193_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","volume":"276","author":"B Allard","year":"2017","unstructured":"Allard B, Longhi MS, Robson SC et al (2017) The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets. Immunol Rev 276:121\u2013144. https:\/\/doi.org\/10.1111\/imr.12528","journal-title":"Immunol Rev"},{"key":"10193_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11302-024-10040-z","volume":"21","author":"GB da Silva","year":"2025","unstructured":"da Silva GB, Manica D, Dallagnol P et al (2025) Rosmarinic acid modulates purinergic signaling and induces apoptosis in melanoma cells. Purinergic Signal 21:353\u2013363. https:\/\/doi.org\/10.1007\/s11302-024-10040-z","journal-title":"Purinergic Signal"},{"key":"10193_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110427","volume":"375","author":"GB Da Silva","year":"2023","unstructured":"Da Silva GB, Manica D, Da Silva AP et al (2023) Rosmarinic acid decreases viability, inhibits migration and modulates expression of apoptosis-related CASP8\/CASP3\/NLRP3 genes in human metastatic melanoma cells. Chem Biol Interact 375:110427. https:\/\/doi.org\/10.1016\/j.cbi.2023.110427","journal-title":"Chem Biol Interact"},{"key":"10193_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11302-023-09967-6","volume":"20","author":"D Manica","year":"2024","unstructured":"Manica D, Da Silva GB, De Lima J et al (2024) Caffeine reduces viability, induces apoptosis, inhibits migration and modulates the CD39\/CD73 axis in metastatic cutaneous melanoma cells. Purinergic Signal 20:385\u2013397. https:\/\/doi.org\/10.1007\/s11302-023-09967-6","journal-title":"Purinergic Signal"},{"key":"10193_CR30","doi-asserted-by":"publisher","first-page":"9992","DOI":"10.1002\/jcb.28281","volume":"120","author":"MD Bagatini","year":"2019","unstructured":"Bagatini MD, Bertolin K, Bridi A et al (2019) 1\u03b1,25-Dihydroxyvitamin D3 alters ectonucleotidase expression and activity in human cutaneous melanoma cells. J Cell Biochem 120:9992\u201310000. https:\/\/doi.org\/10.1002\/jcb.28281","journal-title":"J Cell Biochem"},{"key":"10193_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/nu16172929","volume":"16","author":"FT Borsoi","year":"2024","unstructured":"Borsoi FT, da Silva GB, Manica D et al (2024) Extract of ara\u00e7\u00e1-boi and its major phenolic compound, trans-cinnamic acid, reduce viability and inhibit migration of human metastatic melanoma cells. Nutrients 16:2929. https:\/\/doi.org\/10.3390\/nu16172929","journal-title":"Nutrients"},{"key":"10193_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085311","volume":"9","author":"BV Jardim-Perassi","year":"2014","unstructured":"Jardim-Perassi BV, Arbab AS, Ferreira LC et al (2014) Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer. PLoS ONE 9:e85311. https:\/\/doi.org\/10.1371\/journal.pone.0085311","journal-title":"PLoS ONE"},{"key":"10193_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.mrgentox.2018.04.002","volume":"829\u2013830","author":"A Kocyigit","year":"2018","unstructured":"Kocyigit A, Guler EM, Karatas E et al (2018) Dose-dependent proliferative and cytotoxic effects of melatonin on human epidermoid carcinoma and normal skin fibroblast cells. Mutat Res Genet Toxicol Environ Mutagen 829\u2013830:50\u201360. https:\/\/doi.org\/10.1016\/j.mrgentox.2018.04.002","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"key":"10193_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4","journal-title":"J Immunol Methods"},{"key":"10193_CR35","doi-asserted-by":"publisher","first-page":"7652","DOI":"10.1039\/D1RA09021F","volume":"12","author":"K G\u0142owacz","year":"2022","unstructured":"G\u0142owacz K, Skorupska S, Grabowska-Jadach I et al (2022) Excitation\u2013emission matrix fluorescence spectroscopy for cell viability testing in UV-treated cell culture. RSC Adv 12:7652\u20137660. https:\/\/doi.org\/10.1039\/D1RA09021F","journal-title":"RSC Adv"},{"issue":"2","key":"10193_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.2144\/000113610","volume":"50","author":"SW Perry","year":"2011","unstructured":"Perry SW, Norman JP, Barbieri J, Brown EB, Gelbard HA (2011) Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 50(2):98\u2013115. https:\/\/doi.org\/10.2144\/000113610","journal-title":"Biotechniques"},{"key":"10193_CR37","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot087361","author":"LC Crowley","year":"2016","unstructured":"Crowley LC, Christensen ME, Waterhouse NJ (2016) Measuring mitochondrial transmembrane potential by TMRE staining. Cold Spring Harb Protoc. https:\/\/doi.org\/10.1101\/pdb.prot087361","journal-title":"Cold Spring Harb Protoc"},{"key":"10193_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/09537109609023582","volume":"7","author":"C Pilla","year":"1996","unstructured":"Pilla C, Emanuelli T, Frassetto SS et al (1996) ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets 7:225\u2013230. https:\/\/doi.org\/10.3109\/09537109609023582","journal-title":"Platelets"},{"key":"10193_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0049-3848(03)00178-6","volume":"109","author":"GI Lunkes","year":"2003","unstructured":"Lunkes GI, Lunkes D, Stefanello F et al (2003) Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 109:189\u2013194. https:\/\/doi.org\/10.1016\/S0049-3848(03)00178-6","journal-title":"Thromb Res"},{"key":"10193_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25:402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"key":"10193_CR41","doi-asserted-by":"publisher","first-page":"18886","DOI":"10.3390\/molecules201018886","volume":"20","author":"D-X Tan","year":"2015","unstructured":"Tan D-X, Manchester L, Esteban-Zubero E et al (2015) Melatonin as a potent and inducible endogenous antioxidant: synthesis and metabolism. Molecules 20:18886\u201318906. https:\/\/doi.org\/10.3390\/molecules201018886","journal-title":"Molecules"},{"key":"10193_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914947","volume":"24","author":"JKS M\u00f6ller","year":"2023","unstructured":"M\u00f6ller JKS, Linowiecka K, Gagat M et al (2023) Melanogenesis is directly affected by metabolites of melatonin in human melanoma cells. Int J Mol Sci 24:14947. https:\/\/doi.org\/10.3390\/ijms241914947","journal-title":"Int J Mol Sci"},{"key":"10193_CR43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/exd.14715","volume":"32","author":"M Mubashshir","year":"2023","unstructured":"Mubashshir M, Ahmad N, Sk\u00f6ld HN et al (2023) An exclusive review of melatonin effects on mammalian melanocytes and melanoma. Exp Dermatol 32:324\u2013330. https:\/\/doi.org\/10.1111\/exd.14715","journal-title":"Exp Dermatol"},{"key":"10193_CR44","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/jpi.12321","volume":"60","author":"SM Muxel","year":"2016","unstructured":"Muxel SM, Laranjeira-Silva MF, Carvalho-Sousa CE et al (2016) The RelA\/cRel nuclear factor-\u03baB (NF-\u03baB) dimer, crucial for inflammation resolution, mediates the transcription of the key enzyme in melatonin synthesis in RAW 264.7 macrophages. J Pineal Res 60:394\u2013404. https:\/\/doi.org\/10.1111\/jpi.12321","journal-title":"J Pineal Res"},{"key":"10193_CR45","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.4103\/jcrt.JCRT_682_19","volume":"16","author":"M Kahkesh","year":"2020","unstructured":"Kahkesh M, Salehi Z, Najafi M et al (2020) The inhibitory effect of melatonin on the proliferation of irradiated A549 cell line. J Cancer Res Ther 16:1500\u20131505. https:\/\/doi.org\/10.4103\/jcrt.JCRT_682_19","journal-title":"J Cancer Res Ther"},{"key":"10193_CR46","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/cpr.12140","volume":"47","author":"P Plaimee","year":"2014","unstructured":"Plaimee P, Weerapreeyakul N, Thumanu K et al (2014) Melatonin induces apoptosis through biomolecular changes, in SK-LU-1 human lung adenocarcinoma cells. Cell Prolif 47:564\u2013577. https:\/\/doi.org\/10.1111\/cpr.12140","journal-title":"Cell Prolif"},{"key":"10193_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.21037\/tau-21-1110","volume":"11","author":"L Hao","year":"2022","unstructured":"Hao L, Dong Y, Zhang J-J et al (2022) Melatonin decreases androgen-sensitive prostate cancer growth by suppressing SENP1 expression. Transl Androl Urol 11:91\u2013103. https:\/\/doi.org\/10.21037\/tau-21-1110","journal-title":"Transl Androl Urol"},{"key":"10193_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154637","volume":"248","author":"MS Cucielo","year":"2023","unstructured":"Cucielo MS, Freire PP, Em\u00edlio-Silva MT et al (2023) Melatonin enhances cell death and suppresses the metastatic capacity of ovarian cancer cells by attenuating the signaling of multiple kinases. Pathol Res Pract 248:154637. https:\/\/doi.org\/10.1016\/j.prp.2023.154637","journal-title":"Pathol Res Pract"},{"key":"10193_CR49","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.bone.2013.02.021","volume":"55","author":"L Liu","year":"2013","unstructured":"Liu L, Xu Y, Reiter RJ (2013) Melatonin inhibits the proliferation of human osteosarcoma cell line MG-63. Bone 55:432\u2013438. https:\/\/doi.org\/10.1016\/j.bone.2013.02.021","journal-title":"Bone"},{"key":"10193_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317705758","author":"R Kumari","year":"2017","unstructured":"Kumari R, Rawat K, Kumari A et al (2017) Amelioration of Dalton\u2019s lymphoma-induced angiogenesis by melatonin. Tumour Biol. https:\/\/doi.org\/10.1177\/1010428317705758","journal-title":"Tumour Biol"},{"key":"10193_CR51","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41586-020-2078-2","volume":"579","author":"X Guo","year":"2020","unstructured":"Guo X, Aviles G, Liu Y et al (2020) Mitochondrial stress is relayed to the cytosol by an OMA1\u2013DELE1\u2013HRI pathway. Nature 579:427\u2013432. https:\/\/doi.org\/10.1038\/s41586-020-2078-2","journal-title":"Nature"},{"key":"10193_CR52","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana S, Malireddi RKS, Kanneganti T-D (2020) Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol 38:567\u2013595. https:\/\/doi.org\/10.1146\/annurev-immunol-073119-095439","journal-title":"Annu Rev Immunol"},{"key":"10193_CR53","doi-asserted-by":"publisher","first-page":"16981","DOI":"10.3390\/ijms160816981","volume":"16","author":"A S\u00e1nchez","year":"2015","unstructured":"S\u00e1nchez A, Calpena A, Clares B (2015) Evaluating the oxidative stress in inflammation: role of melatonin. Int J Mol Sci 16:16981\u201317004. https:\/\/doi.org\/10.3390\/ijms160816981","journal-title":"Int J Mol Sci"},{"key":"10193_CR54","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883\u2013899. https:\/\/doi.org\/10.1016\/j.cell.2010.01.025","journal-title":"Cell"},{"key":"10193_CR55","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1038\/s12276-023-01078-x","volume":"55","author":"W Park","year":"2023","unstructured":"Park W, Wei S, Kim B-S et al (2023) Diversity and complexity of cell death: a historical review. Exp Mol Med 55:1573\u20131594. https:\/\/doi.org\/10.1038\/s12276-023-01078-x","journal-title":"Exp Mol Med"},{"key":"10193_CR56","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41420-025-02328-9","volume":"11","author":"G Eskander","year":"2025","unstructured":"Eskander G, Abdelhamid SG, Wahdan SA et al (2025) Insights on the crosstalk among different cell death mechanisms. Cell Death Discov 11:56. https:\/\/doi.org\/10.1038\/s41420-025-02328-9","journal-title":"Cell Death Discov"},{"key":"10193_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107731","volume":"31","author":"K Berthenet","year":"2020","unstructured":"Berthenet K, Castillo Ferrer C, Fanfone D et al (2020) Failed apoptosis enhances melanoma cancer cell aggressiveness. Cell Rep 31:107731. https:\/\/doi.org\/10.1016\/j.celrep.2020.107731","journal-title":"Cell Rep"},{"key":"10193_CR58","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1111\/bph.14083","volume":"175","author":"RP Markus","year":"2018","unstructured":"Markus RP, Fernandes PA, Kinker GS et al (2018) Immune-pineal axis \u2013 acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes. Br J Pharmacol 175:3239\u20133250. https:\/\/doi.org\/10.1111\/bph.14083","journal-title":"Br J Pharmacol"},{"key":"10193_CR59","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc.2017.86","volume":"17","author":"D Vijayan","year":"2017","unstructured":"Vijayan D, Young A, Teng MWL et al (2017) Targeting immunosuppressive adenosine in cancer. Nat Rev Cancer 17:709\u2013724. https:\/\/doi.org\/10.1038\/nrc.2017.86","journal-title":"Nat Rev Cancer"},{"key":"10193_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.imlet.2018.05.001","volume":"205","author":"D Allard","year":"2019","unstructured":"Allard D, Chrobak P, Allard B et al (2019) Targeting the CD73-adenosine axis in immuno-oncology. Immunol Lett 205:31\u201339. https:\/\/doi.org\/10.1016\/j.imlet.2018.05.001","journal-title":"Immunol Lett"},{"key":"10193_CR61","doi-asserted-by":"publisher","first-page":"C832","DOI":"10.1152\/ajpcell.00053.2020","volume":"318","author":"F Di Virgilio","year":"2020","unstructured":"Di Virgilio F, Sarti AC, Coutinho-Silva R (2020) Purinergic signaling, DAMPs, and inflammation. Am J Physiol Cell Physiol 318:C832\u2013C835. https:\/\/doi.org\/10.1152\/ajpcell.00053.2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"10193_CR62","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","volume":"18","author":"F Di Virgilio","year":"2018","unstructured":"Di Virgilio F, Sarti AC, Falzoni S et al (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer 18:601\u2013618. https:\/\/doi.org\/10.1038\/s41568-018-0037-0","journal-title":"Nat Rev Cancer"},{"key":"10193_CR63","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00441-005-1149-x","volume":"321","author":"N White","year":"2005","unstructured":"White N, Butler PEM, Burnstock G (2005) Human melanomas express functional P2X7 receptors. Cell Tissue Res 321:411\u2013418. https:\/\/doi.org\/10.1007\/s00441-005-1149-x","journal-title":"Cell Tissue Res"},{"key":"10193_CR64","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s11302-009-9156-0","volume":"5","author":"N White","year":"2009","unstructured":"White N, Knight GE, Butler PEM et al (2009) An in vivo model of melanoma: treatment with ATP. Purinergic Signal 5:327\u2013333. https:\/\/doi.org\/10.1007\/s11302-009-9156-0","journal-title":"Purinergic Signal"},{"key":"10193_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113959","volume":"21","author":"A Wilkaniec","year":"2020","unstructured":"Wilkaniec A, Cie\u015blik M, Murawska E et al (2020) P2X7 receptor is involved in mitochondrial dysfunction induced by extracellular alpha synuclein in neuroblastoma SH-SY5Y cells. Int J Mol Sci 21:3959. https:\/\/doi.org\/10.3390\/ijms21113959","journal-title":"Int J Mol Sci"},{"key":"10193_CR66","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1038\/s41388-019-0684-y","volume":"38","author":"E De Marchi","year":"2019","unstructured":"De Marchi E, Orioli E, Pegoraro A et al (2019) The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumour microenvironment. Oncogene 38:3636\u20133650. https:\/\/doi.org\/10.1038\/s41388-019-0684-y","journal-title":"Oncogene"},{"key":"10193_CR67","doi-asserted-by":"publisher","first-page":"694831","DOI":"10.3389\/fcell.2021.694831","volume":"9","author":"F Grassi","year":"2021","unstructured":"Grassi F, De Ponte CB (2021) The P2X7 receptor in tumor immunity. Front Cell Dev Biol 9:694831. https:\/\/doi.org\/10.3389\/fcell.2021.694831","journal-title":"Front Cell Dev Biol"},{"key":"10193_CR68","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.jid.2019.12.035","volume":"140","author":"Y Ahn","year":"2020","unstructured":"Ahn Y, Seo J, Lee EJ et al (2020) ATP-P2X7-induced inflammasome activation contributes to melanocyte death and CD8+ T-cell trafficking to the skin in vitiligo. J Invest Dermatol 140:1794\u20131804. https:\/\/doi.org\/10.1016\/j.jid.2019.12.035","journal-title":"J Invest Dermatol"},{"key":"10193_CR69","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/01.cmr.0000215030.69823.11","volume":"16","author":"R Sadej","year":"2006","unstructured":"Sadej R, Spychala J, Skladanowski AC (2006) Expression of ecto-5\u2032-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma. Melanoma Res 16:213\u2013222. https:\/\/doi.org\/10.1097\/01.cmr.0000215030.69823.11","journal-title":"Melanoma Res"},{"key":"10193_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212433","volume":"25","author":"K Horodecka","year":"2024","unstructured":"Horodecka K, Czernek L, P\u0119czek \u0141 et al (2024) Impact of Rab27 on melanoma cell invasion and sEV secretion. Int J Mol Sci 25:12433. https:\/\/doi.org\/10.3390\/ijms252212433","journal-title":"Int J Mol Sci"},{"key":"10193_CR71","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11302-024-10037-8","volume":"21","author":"RP Markus","year":"2025","unstructured":"Markus RP, Sousa KS, Ulrich H et al (2025) Partners in health and disease: pineal gland and purinergic signalling. Purinergic Signal 21:99\u2013112. https:\/\/doi.org\/10.1007\/s11302-024-10037-8","journal-title":"Purinergic Signal"},{"key":"10193_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-017-1348-8","volume":"15","author":"S Morello","year":"2017","unstructured":"Morello S, Capone M, Sorrentino C et al (2017) Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab. J Transl Med 15:244. https:\/\/doi.org\/10.1186\/s12967-017-1348-8","journal-title":"J Transl Med"},{"key":"10193_CR73","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/jpi.12162","volume":"57","author":"HM Zhang","year":"2014","unstructured":"Zhang HM, Zhang Y (2014) Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 57:131\u2013146. https:\/\/doi.org\/10.1111\/jpi.12162","journal-title":"J Pineal Res"},{"key":"10193_CR74","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.3390\/antiox11081621","volume":"11","author":"J Florido","year":"2022","unstructured":"Florido J, Rodriguez-Santana C, Martinez-Ruiz L et al (2022) Understanding the mechanism of action of melatonin, which induces ROS production in cancer cells. Antioxidants (Basel) 11:1621. https:\/\/doi.org\/10.3390\/antiox11081621","journal-title":"Antioxidants (Basel)"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10193-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10193-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-026-10193-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:02:42Z","timestamp":1792566162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-026-10193-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10193"],"URL":"https:\/\/doi.org\/10.1007\/s11302-026-10193-z","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}],"article-number":"81"}}